SCHEMBL3511786

SCHEMBL3511786

C1=CCN(c2occ3ccccc23)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 3/20 0.38
NPY5R Q15761 1/20 0.33
CRHR1 P34998 1/20 0.33
MAOA P21397 2/20 0.33
GAA P10253 2/20 0.31
NCF1 P14598 2/20 0.31
APAF1 O14727 1/20 0.31
CDC25B P30305 1/20 0.31
CASP3 P42574 1/20 0.31
SENP8 Q96LD8 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
HPGD P15428 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNA4 P43681 1/20 0.31
HTR3E A5X5Y0 2/20 0.31
HTR3B O95264 2/20 0.31
HTR3A P46098 2/20 0.31
HTR3D Q70Z44 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17924061 0.79 HPGD (0.38) KDM4EALDH1A1GAANCF1HPGD
SCHEMBL3512417 0.77 HPGD (0.46) KDM4EALDH1A1GAANCF1HPGD
Hydrochloric Acid SCHEMBL3815877 0.70 APAF1 (0.35) KDM4EALDH1A1APAF1CDC25BCASP3
Bromide SCHEMBL9444674 0.69 HTR1A (0.54) KDM4EALDH1A1NCF1HPGDHTR3E
Hydrochloric Acid SCHEMBL4206560 0.66 ALDH1A1 (0.30) ALDH1A1HTR3ATSHR
SCHEMBL3511781 0.66 PRKDC (0.44) KDM4EALDH1A1MAOAHPGDSMN1; SMN2
SCHEMBL1889513 0.64 LMNA (0.46) ALDH1A1MAOAGAAHPGDSMN1; SMN2
SCHEMBL2048248 0.62 ADRB1 (0.53) ALDH1A1HPGDSMN1; SMN2MAPTTSHR
SCHEMBL1097671 0.61 CYP2A6 (0.42) KDM4EALDH1A1GAAHPGDSMN1; SMN2
SCHEMBL7826599 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100247543-A1 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES ORYZON GENOMICS, S.A. (ES) 2010-09-30 US disclosed
EP-2195029-A2 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES Oryzon Genomics SA (ES) 2010-06-16 EP disclosed
WO-2009027349-A2 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES ORYZON GENOMICS SA (ES) 2009-03-05 WO disclosed
US-4600719-A Tetrahydropyridine and piperidine derivatives CIBA GEIGY CORPORATION (US) 1986-07-15 US disclosed
US-4210655-A Anti-depressant benzofuranyl piperidines CIBA-GEIGY CORPORATION (US) 1980-07-01 US disclosed